CELT's first in-person meeting of the community of practice for long-acting therapeutics for maternal and paediatric health
Below is the agenda for the first in-person meeting of the community of practice.
CELT's Community of Practice for Long-acting therapeutics for maternal and paediatric health
1 July 2025, The Spine, Liverpool UK
Agenda
| 09:00 | Registration | |
|---|---|---|
| 09:30 | Welcome and Overview - Professor Andrew Owen | |
Session 1: Long-acting therapeutics in maternal health |
Chair: Ethel Weld |
|
| 09:35 | Sharon Nachman IMPAACT Network |
Maternal health priorities – Identifying where the need is greatest |
| 09:55 | Rachel Scott MedStar Health Research Institute/ IMPAACT Network |
Pharmacokinetics and safety considerations for long-acting therapeutics: use during pregnancy and breastfeeding |
| 10:15 | Dr Adeniyi Olagunju CELT Perinatal Pharmacology Group University of Liverpool |
Long-acting therapeutic technologies and innovations: potential applications for women’s health priorities |
| 10:35 | Discussion | |
| 11:00 | Refreshment break | |
Session 2: Long-acting therapeutics in paediatric health |
Chair: Rachel Daley |
|
| 11:20 | Professor Moherndran Archary University of Kwa-Zulu Natal |
Paediatric health priorities – Identifying where the need is greatest |
| 11:40 | Edmund Capparelli University of California, San Diego |
Pharmacokinetics and safety considerations for long-acting therapeutics: use in children |
| 12:00 | Prajith Venkatasubramanian CELT Perinatal Pharmacology Group University of Liverpool |
Long-acting therapeutic technologies and innovations: potential applications for paediatric health priorities |
| 12:20 | Discussion | |
| 12:45 |
Lunch | |
Session 3: Long-acting therapeutics in global health |
Chair: Grace Miheso |
|
| 13:45 | Martina Penazzato World Health Organisation |
Partnering across the end to end to address the needs of underrepresented populations |
| 13:55 | Brighton Mphako – SAHPRA Patrick GAD – Rwanda FDA Nathaniel Nana Kwabena Nkrumah – Ghana FDA Kim Struble - FDA |
Panel discussion: Enabling long-acting therapeutics development and use for maternal and paediatric health through regulation |
| 14:40 | Andre Tchouatieu - MMV Brenda Okware - Gilead | Lessons from a real-world long-acting development programme |
| 15:20 | Refreshments break | |
Breakout Sessions |
Chair: Rachel Daley |
|
| 15:40 | Sessions: Maternal – Dr Odula Paediatric - Mili Karina Regulatory/ethics – Osei Boateng Access – Pierre Gashema |
Each breakout session will synthesise learning from the workshop and recommend action plans for progress that will feed into a white paper. |
| 16:25 | Refreshment break | |
| 16:35 | Breakout sessions feedback | Summary of discussion from each breakout session by rapporteur (5 mins each) |
| 16:55 | Closing remarks by Dr Adeniyi Olagunju | |
| 17:00 | Close | |
